Prediction of post-operative complications among diabetic patients undergoing major surgery using biomarkers

Area of Science:

• Biomedical Science
• Surgical Oncology
• Clinical Chemistry

Background:

• Diabetes mellitus is a prevalent comorbidity in patients undergoing major surgery.
• Perioperative complications significantly impact patient outcomes and healthcare costs.
• Predictive biomarkers for surgical risk stratification are crucial for optimizing patient management.

Purpose of the Study:

• To evaluate the association between pre-operative biomarkers and postoperative complications in diabetic patients.
• To assess the predictive value of HbA1c, CRP, IL-6, and procalcitonin for surgical outcomes.
• To determine the utility of biomarker profiling in identifying high-risk surgical patients.

Main Methods:

• Prospective evaluation of 150 diabetic patients undergoing major surgery.
• Measurement of pre-operative HbA1c, CRP, IL-6, and procalcitonin levels.
• Correlation analysis between biomarker levels and postoperative complications (e.g., wound infections, ICU stay).

Main Results:

• Elevated pre-operative HbA1c (>8%) and CRP levels were strongly associated with increased postoperative complications.
• Interleukin-6 (IL-6) and procalcitonin demonstrated moderate predictive accuracy for systemic inflammation.
• Biomarker profiling effectively identified patients at higher risk for adverse surgical outcomes.

Conclusions:

• Pre-operative HbA1c and CRP are valuable predictors of postoperative complications in diabetic surgical patients.
• Integrating these biomarkers into pre-operative assessments can enhance risk stratification.
• Biomarker-guided surgical planning and postoperative care can potentially improve patient outcomes.